Strategic Blueprint’s HCA Healthcare HCA Stock Holding History

Strategic Blueprint’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	-$1K	–	784
2021 Q2	$1K	Buy	+3	New	+$611	﹤0.01%	1315

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Strategic Blueprint's HCA Position: Q3 2021 in Review

Strategic Blueprint sold out of HCA Healthcare (HCA) in Q3 2021, closing a stake of 3 shares — an estimated $1K sold.

Strategic Blueprint first reported a position in HCA in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 885 funds tracked by Wall St. Rank hold HCA as of Q3 2021.

Strategic Blueprint reported no remaining HCA Healthcare position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 3 HCA Healthcare shares in Q3 2021, an estimated $1K.
Strategic Blueprint first reported a position in HCA Healthcare in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's HCA Healthcare position peaked at $1K in Q2 2021.
885 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.